---
input_text: 'Treatment of Severe Kyphoscoliosis in Children with Mucopolysaccharidosis
  Type I (Pfaundler-Hurler Syndrome) Using the Growing Rod Technique: A Case Series
  with Mid-Term Results. BACKGROUND: Patients with mucopolysaccharidosis type I (MPS
  I) have a good life expectancy due to early therapeutic options, such as stem cell
  therapy. Stem cell therapy can prevent the progression of some skeletal malformations.
  In contrast, the progression of thoracolumbar kyphoscoliosis, genua vara, and hip
  dysplasia cannot be influenced. We present 3 cases of children with MPS I with thoracolumbar
  kyphosis/kyphoscoliosis treated with a growing rod system. CASE DESCRIPTION: The
  medical records and radiologic imaging of 3 children with a diagnosis of MPS I and
  kyphosis/kyphoscoliosis of the lumbar spine treated between 2007 and 2019 were retrospectively
  analyzed. Two children presented with a kyphoscoliosis, and 1 child had a combination
  of severe anterolisthesis and kyphoscoliosis. Surgery to correct the kyphosis and
  dorsal stabilization was performed in all patients after exhausted conservative
  treatment. There were no neurologic complications. Postoperative treatment and aftercare
  included a corset for 4 months and physical therapy. In all 3 patients, distraction
  surgery of the lumbar stabilization was done twice at a mean interval of 1 year.
  CONCLUSIONS: If conservative treatment fails and surgery is necessary, an individual
  approach is needed. Dorsal stabilization with pedicle screws using a growing rod
  technique is an option for the correction of thoracolumbar/lumbar kyphosis in children
  with MPS I. However, fusion should be prevented initially or should be kept as short
  as possible. We achieved acceptable correction of the spinal deformity using the
  growing rod technique. Finally, surgery with correction and fusion is necessary
  after exhausted correction potential.'
raw_completion_output: |-
  primary_disease: Mucopolysaccharidosis Type I (MPS I)

  medical_actions: Stem cell therapy; Surgery to correct kyphosis and dorsal stabilization; Use of a corset; Physical therapy; Distraction surgery of the lumbar stabilization with pedicle screws using a growing rod technique; Surgery with correction and fusion

  symptoms: Thoracolumbar kyphoscoliosis; Genua vara; Hip dysplasia; Kyphosis/Kyphoscoliosis of the lumbar spine; Severe anterolisthesis

  chemicals: 

  action_annotation_relationships: Stem cell therapy PREVENTS progression of skeletal malformations IN Mucopolysaccharidosis Type I (MPS I); Surgery to correct kyphosis and dorsal stabilization TREATS Thoracolumbar kyphoscoliosis IN Mucopolysaccharidosis Type I (MPS I); Use of a corset TREATS Kyphosis/Kyphoscoliosis of the lumbar spine IN Mucopolysaccharidosis Type I (MPS I); Physical therapy TREATS Kyphosis/Kyphoscoliosis of the lumbar spine IN Mucopolysaccharidosis Type I (MPS I); Distraction surgery of the lumbar stabilization with pedicle screws using a growing rod technique TREATS Kyphosis/Kyphoscoliosis of the lumbar spine IN Mucopolysaccharidosis Type I (MPS I); Surgery with correction and fusion TREATS Thoracolumbar kyphoscoliosis IN Mucopolysaccharidosis Type I (MPS I)
prompt: |+
  From the text below, extract the following entities in the following format:

  subject_extension: <A chemical or drug mentioned in the relationship between the medical action and the symptom, for example, "analgesic agent therapy" has the aspect "analgesic">
  object_extension: <An optional term describing some specific aspect of the object, e.g. "analgesic agent therapy" has the aspect "analgesic">
  subject: <The medical action. For example: blood transfusion, radiation therapy, cardiac catheterization, pulse oximetry, otoscopy>
  predicate: <The relationship type between the medical action and the symptom, usually TREATS or PREVENTS.>
  object: <A sign or symptom associated with the disease and targeted by the medical action. For example, Low serum calcitriol, hypoplasia of the thymus, chronic cough, aortic stiffness, low pulse pressure>
  qualifier: <The primary disease the relationship is about, or specifically the disease the symptom is related to. For example, Beck-Fahrner syndrome, hereditary retinoblastoma, progeria, diabetes mellitus, infectious otitis media>
  subject_qualifier: <An optional qualifier or modifier for the subject of the statement, e.g. "high dose" or "intravenously administered">
  object_qualifier: <An optional qualifier or modifier for the object of the statement, e.g. "severe" or "with additional complications">


  Text:
  Surgery with correction and fusion TREATS Thoracolumbar kyphoscoliosis IN Mucopolysaccharidosis Type I (MPS I)

  ===

extracted_object:
  primary_disease: MONDO:1012617
  medical_actions:
    - Stem cell therapy
    - Surgery to correct kyphosis and dorsal stabilization
    - Use of a corset
    - MAXO:0000011
    - Distraction surgery of the lumbar stabilization with pedicle screws using a
      growing rod technique
    - Surgery with correction and fusion
  symptoms:
    - HP:0003423
    - HP:0002970
    - HP:0001385
    - Kyphosis/Kyphoscoliosis of the lumbar spine
    - Severe anterolisthesis
  action_annotation_relationships:
    - subject: Stem cell therapy
      predicate: PREVENTS
      object: progression of skeletal malformations
      qualifier: MONDO:1012617
    - subject: Surgery to correct kyphosis and dorsal stabilization
      predicate: TREATS
      object: HP:0003423
      qualifier: MONDO:1012617
    - subject: Use of a corset
      predicate: TREATS
      object: Kyphosis/Kyphoscoliosis of the lumbar spine
      qualifier: MONDO:1012617
      subject_extension: corset
    - subject: MAXO:0000011
      predicate: TREATS
      object: Kyphosis/Kyphoscoliosis of the lumbar spine
      qualifier: MONDO:1012617
    - subject: Distraction surgery of the lumbar stabilization with pedicle screws
      predicate: TREATS
      object: Kyphosis/Kyphoscoliosis of the lumbar spine
      qualifier: MONDO:1012617
      subject_extension: growing rod technique
    - subject: Surgery with correction and fusion
      predicate: TREATS
      object: HP:0003423
      qualifier: MONDO:1012617
named_entities:
  - id: MONDO:0001586
    label: mucopolysaccharidosis type I
  - id: MONDO:1012617
    label: Mucopolysaccharidosis Type I (MPS I)
  - id: CHEBI:60285
    label: DOPE
  - id: MAXO:0001521
    label: nasal administration
  - id: MONDO:0011758
    label: Mucopolysaccharidosis type I Hurler (MPSIH)
  - id: MAXO:0000747
    label: hematopoietic stem cell transplantation (HSCT)
  - id: MAXO:0000487
    label: clinical assessment (growth measurement, kyphosis and genu velgum evaluation)
  - id: HP:0002808
    label: kyphosis
  - id: HP:0001376
    label: limited joint mobility
  - id: HP:0008807
    label: acetabular dysplasia
  - id: MAXO:0010034
    label: Corneal transplantation
  - id: HP:0007957
    label: Corneal clouding
  - id: MAXO:0000149
    label: Hematopoietic cell transplantation (HCT)
  - id: HP:0000238
    label: Hydrocephalus
  - id: MAXO:0000068
    label: transplantation
  - id: MAXO:0000004
    label: surgery
  - id: MAXO:0000526
    label: clinical examination
  - id: CHEBI:143889
    label: glycosaminoglycan (GAG)
  - id: HP:0004322
    label: short stature
  - id: HP:0005619
    label: thoracolumbar kyphosis
  - id: HP:0000943
    label: dysostosis multiplex
  - id: MONDO:0011759
    label: Hurler-Scheie syndrome
  - id: HP:0001387
    label: joint stiffness
  - id: HP:0000403
    label: recurrent otitis media
  - id: HP:0001999
    label: facial dysmorphism
  - id: HP:0002781
    label: Upper airway obstruction
  - id: HP:0001638
    label: Cardiomyopathy
  - id: MAXO:0001479
    label: Allogeneic hematopoietic stem cell transplantation
  - id: MAXO:0001001
    label: Gene therapy
  - id: CHEBI:58187
    label: Alginate
  - id: CHEBI:53412
    label: PLL (Poly-L-lysine)
  - id: CHEBI:50594
    label: Carbon nanotubes
  - id: HP:0007663
    label: Reduced visual acuity
  - id: MAXO:0000016
    label: cellular therapy
  - id: CHEBI:19226
    label: Tm
  - id: MONDO:0017385
    label: mucopolysaccharidosis type I (MPSI) Hurler
  - id: MAXO:0000018
    label: Biomarker assessment
  - id: HP:0001138
    label: Optic neuropathy
  - id: HP:0000488
    label: Retinopathy
  - id: MONDO:0019052
    label: Inborn errors of metabolism
  - id: CHEBI:28901
    label: Busulfan
  - id: CHEBI:33310
    label: MCT (NE)
  - id: HP:0001367
    label: joint disease
  - id: HP:0002652
    label: skeletal dysplasia
  - id: HP:0000618
    label: vision impairments
  - id: HP:0000365
    label: hearing impairments
  - id: MONDO:0007147
    label: Obstructive sleep apnea syndrome (OSAS)
  - id: MAXO:0000915
    label: Overnight polysomnography (PSG)
  - id: HP:0002104
    label: Apnea
  - id: HP:0040213
    label: Hypopnea
  - id: MAXO:0010033
    label: Umbilical cord blood transplantation
  - id: MONDO:0009290
    label: Pompe Disease
  - id: HP:0005162
    label: Left ventricular failure
  - id: HP:0011675
    label: Conduction abnormalities
  - id: HP:0001677
    label: Coronary artery disease
  - id: HP:0001433
    label: Hepatosplenomegaly
  - id: HP:0033126
    label: Necrosis
  - id: CHEBI:46793
    label: 1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-(amino[polyethylene glycol]-
      2000) (DSPE-PEG)
  - id: CHEBI:17754
    label: Glycerol
  - id: CHEBI:15377
    label: Water
  - id: CHEBI:27881
    label: Resveratrol
  - id: HP:0010864
    label: severe mental retardation
  - id: CHEBI:82467
    label: Evans blue
  - id: MONDO:0006249
    label: mucopolysaccharidoses (MPS)
  - id: CHEBI:232920
    label: Alginate-poly-L-lysine-alginate (APA)
  - id: HP:0000708
    label: Behavioral abnormalities
  - id: HP:0033429
    label: Neuroinflammation
  - id: MAXO:0001525
    label: Intravenous administration
  - id: HP:6000847
    label: cardiac mass
  - id: HP:0012393
    label: Allergic reactions
  - id: HP:0001268
    label: Cognitive decline
  - id: HP:0000388
    label: Otitis media
  - id: HP:0000750
    label: Language delays
  - id: MAXO:0000479
    label: Orthopedic surgeries
  - id: HP:0011947
    label: Respiratory infections
  - id: CHEBI:28088
    label: Genistein
  - id: MAXO:0000506
    label: Non-invasive ventilation
  - id: HP:0002091
    label: Restrictive lung disease
  - id: HP:0001513
    label: Obesity
  - id: HP:0000822
    label: High blood pressure
  - id: HP:0001626
    label: Cardiovascular abnormalities
  - id: CHEBI:18376
    label: dermatan sulfate
  - id: CHEBI:28815
    label: heparan sulfate
  - id: CHEBI:37397
    label: chondroitin sulfate
  - id: CHEBI:15971
    label: heparan sulfate (HS)
  - id: CHEBI:17053
    label: dermatan sulfate (DS)
  - id: CHEBI:16991
    label: DNA
  - id: HP:0001385
    label: Hip dysplasia
  - id: HP:0001263
    label: Cognitive delay
  - id: CHEBI:50693
    label: Milrinone
  - id: MAXO:0000011
    label: Physical therapy
  - id: HP:0003423
    label: Thoracolumbar kyphoscoliosis
  - id: HP:0002970
    label: Genua vara
